Plasma is a complex substance that contains proteins and circulating nucleic acids and viruses that can be utilised for clinical diagnostics, albeit a precise analysis depends on the plasma being totally free of cells. We proposed the use of a dielectrophoresis (DEP)-active hydrophoretic method to isolate plasma from blood in a high-throughput manner. This microfluidic device consists of anisotropic microstructures embedded on the top of the channel which generate lateral pressure gradients while interdigitised electrodes lay on the bottom of the channel which can push particles or cells into a higher level using a negative DEP force. Large and small particles or cells (3 μm and 10 μm particles, and red blood cells, white blood cells, and platelets) can be focused at the same time in our DEP-active hydrophoretic device at an appropriate flow rate and applied voltage. Based on this principle, all the blood cells were filtrated from whole blood and then the plasma was extracted with a purity of 94.2% and a yield of 16.5% at a flow rate of 10 μL min(-1). This solved the challenging problem caused by the relatively low throughput of the DEP based device. Our DEP-active hydrophoretic device is a flexible and tunable system that can control the lateral positions of particles by modulating the external voltages without redesigning and fabricating a new channel, and because it is easy to operate, it is easily compatible with other microfluidic platforms that are used for further detection.
The chain length of fructan determines
its different physiological
effects. This study is to explore the effects of low-performance inulin
[LPI, degree of polymerization (DP) ≤ 9] and high-performance
inulin (HPI, DP ≥ 23) on obesity-associated liver injury of
high-fat diet (HFD) feeding mice and its underlying mechanism. Eight
weeks of supplementation of C57BL/6J mice with HPI, relative to LPI
(p < 0.05), caused the more efficient improvement
against the HFD-induced liver insulin resistance through activating
IRS1/PI3K/Akt pathway and reduced protein expressions of inflammatory
factors nuclear factor-kappaB (NF-κB) and interleukin-6 (IL-6)
in the liver. HPI exhibited the more positive effects on liver steatosis
by inhibiting acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS),
and sterol regulatory element binding protein 1 (SREBP1) in comparison
with LPI (p < 0.05). HPI also increased acetic
acid, propionic acid, and butyric acid levels in the colon of HFD-fed
mice (p < 0.05). Compared to LPI, HPI feeding
of HFD-fed mice led to the more effective decrease in the Firmicutes
abundance from 72.1% to 34.5%, but a more significant increase in
the Bacteroidetes population from 19.8 to 57.1% at the phyla level,
and increased the abundance of Barnesiella, Bacteroides, and Parabacteroides at the genus level (p < 0.05). Depending on DP, HPI exerts the more positive regulation
on liver injury and gut microbiota dysfunction than LPI.
Fu
brick tea is a unique post-fermented dark tea product which
undergoes controlled fermentation by “golden flower”
fungus Eurotium cristatum. This study examined the
effects of Fu brick tea aqueous extract (FTE) to alleviate insulin
resistance, chronic kidney disease (CKD), and its regulatory mechanism
in high fat diet (HFD)-induced obese rats. Sixteen-week administration
of FTE at 400 mg/kg bw in rats significantly antagonized HFD-induced
insulin resistance and CKD with elevations in serum leptin, TC, TG,
LDL-C, blood urea nitrogen, uric acid, and creatinine levels, respectively
(p < 0.05). FTE treatment decreased the glomerular
area, the thickness of basement membrane of renal tubules, and kidney
fibrosis in HFD-fed rats. FTE alleviated insulin resistance through
down-regulation of SIRP-α expression and activation of the insulin
signaling Akt/GLUT4, FoxO1, and mTOR/S6K1 pathways in skeletal muscle.
Furthermore, FTE prevented the HFD-caused kidney dysfunction and lipid
or collagen accumulation, which was accompanied by the inhibition
of GSK-3β phosphorylation and the action of PI3K/Akt and nuclear
accumulation of Nrf2 in kidney. These results indicated that FTE alleviated
insulin resistance and CKD through modulating insulin signal transduction
cascades in skeletal muscle and enhanced the Nrf2 expression in kidney.
This paper proposes a novel concept of dielectrophoresis (DEP)-active hydrophoretic focusing of micro-particles and murine erythroleukemia (MEL) cells. The DEP-active hydrophoretic platform consists of crescent shaped grooves and interdigitated electrodes that generate lateral pressure gradients. These embedded electrodes exert a negative DEP force onto the particles by pushing them into a narrow space in the channel where the particle to groove interaction is intensive and hydrophoretic ordering occurs. Particles passing through the microfluidic device are directed towards the sidewalls of the channel. The critical limitation of DEP operating at a low flow rate and the specific hydrophoretic device for focusing particles of given sizes were overcome with the proposed microfluidic device. The focusing pattern can be modulated by varying the voltage. High throughput was achieved (maximum flow rate ~150 μL min−1) with good focusing performance. The non-spherical MEL cells were utilised to verify the effectiveness of the DEP-active hydrophoretic device.
Activating adipocyte's thermogenic function is an attractive therapeutic strategy against obesity and its associated metabolic complications. Proanthocyanidins are a class of polyphenols which are widely found in plants and...
This work explores dielectrophoresis (DEP)-active hydrophoresis in sorting particles and cells. The device consists of prefocusing region and sorting region with great potential to be integrated into advanced lab-on-a-chip bioanalysis devices. Particles or cells can be focused in the prefocusing region and then sorted in the sorting region. The DEP-active hydrophoretic sorting is not only based on size but also on dielectric properties of the particles or cells of interest without any labelling. A mixture of 3 and 10 μm particles were sorted and collected from corresponding outlets with high separation efficiency. According to the different dielectric properties of viable and nonviable Chinese Hamster Ovary (CHO) cells at the medium conductivity of 0.03 S/m, the viable CHO cells were focused well and sorted from cell sample with a high purity.
This study explored whether the antiobesity
effect of theabrownin
(TB) extracted from Fu brick tea (FBT) was associated with the activation
of brown adipose tissue (BAT) or browning of the white adipose tissue
(WAT) in mice fed a high-fat diet (HFD). Mice were divided into five
groups, which received a normal diet, HFD, or HFD plus TB (200, 400,
and 800 mg/kg), respectively. A 12-week administration of TB in a
dose-dependent manner reduced the body weight and WAT weight and improved
lipid and glucose disorders in the HFD-fed mice (p < 0.05). TB also promoted the expression of thermogenic and mitochondrial
genes, whereas inflammation genes were reduced in interscapular BAT
(iBAT), inguinal WAT (iWAT), and epididymis white adipose tissue (eWAT),
accompanied by improvement in the intestinal homeostasis by improving
SCFAs, especially butyric acid levels (p < 0.05),
which was related to thermogenic and inflammatory factors of iBAT
and iWAT. Mechanistically, TB was shown to efficiently promote thermogenesis
by stimulating the AMPK-PGC1α pathway with an increase in uncoupling
protein 1 (UCP1). Conclusively, these findings suggest that long-term
consumption of TB can enhance BAT activity and WAT browning by activating
the AMPK-PGC1α pathway and modulating SCFAs; meanwhile, SCFAs
regulating TB improved inflammatory disorder in HFD-fed mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.